Shivalik Rasayan Ltd Q3 FY26 – ₹82 Cr Sales, EPS ₹1.71, ROE 3.2%… Agro Giant or Balance Sheet Gymnast?

1. At a Glance – The Agro-Pharma Cocktail That Markets Can’t Digest

Market Cap ₹474 Cr. Current price ₹301. Down 25.4% in 3 months and a brutal 58.2% in one year. P/E at 41.3. Price to Book at 0.81. ROE at a sleepy 3.20%. ROCE just 5.51%.

Latest Q3 FY26 numbers?
Revenue: ₹82.04 Cr
PAT: ₹3.67 Cr
EPS: ₹1.71

This is India’s largest producer of Dimethoate Technical and second-largest in Malathion Technical, plus it makes oncology APIs with USFDA approval at Dahej. Sounds impressive, right?

But here’s the twist: despite fancy regulatory approvals and greenfield capex stories, the return ratios look like they’re on a government holiday.

Is this a turnaround story in progress… or a capex-heavy balance sheet still catching its breath?

Let’s investigate.

2. Introduction – Agro Chemicals Meet Oncology Dreams

Shivalik Rasayan Ltd, incorporated in 1979, is not some new-age startup burning cash on PowerPoint slides. It’s been around longer than most of us have had demat accounts.

The company operates in two major verticals:

1. Agrochemicals (92% of FY23 revenue)
2. Pharma APIs (8%)

It is:

• India’s largest Dimethoate producer
• Second largest Malathion producer
• Developer of oncology and non-oncology APIs
• USFDA-approved facility holder

On paper, this is a diversified chemical + pharma hybrid.

In reality?

Agrochemicals bring bulk revenue. APIs bring prestige and regulatory bragging rights.

The Dahej facility received USFDA approval in October 2024. A greenfield agro & specialty chemical plant started commercial production from September 2023. That’s ₹120 Cr invested. Add preferential allotment of ₹104 Cr in FY23.

Translation: heavy capital deployment.

But the real question is:

Has that capital started producing serious returns… or is it still in “under construction” mode?

3. Business Model – WTF Do They Even Do?

Let’s simplify this.

Agrochemical Side:

They manufacture organophosphorus-based insecticides like:

• Dimethoate
• Malathion
• Azoxystrobin
• Chlorantraniliprole
• Dinotefuran
• Pymetrozine

Basically, they help farmers eliminate pests that want to eat crops before humans do.

They also filed 34 new agro chemical registrations with CIB&RC. Approvals expected in 18–24 months.

Question: Will approvals translate into revenue or just annual report excitement?

API Side:

They develop oncology and non-oncology APIs.

Achievements:

• 12 APIs developed
• 2 US patents (Highly Pure Fingolimod